{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:23:54Z","timestamp":1792592634983,"version":"4.5.0"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.intimp.2025.114218","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T16:32:12Z","timestamp":1739637132000},"page":"114218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Beyond coagulation: Coagulation protease factor VIIa in cytoprotective response"],"prefix":"10.1016","volume":"150","author":[{"given":"Akash","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhojit","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmoy","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupender","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jcp.1.3.113","article-title":"Normal and abnormal blood coagulation: a review","volume":"1","author":"Macfarlane","year":"1948","journal-title":"J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1152\/physrev.1935.15.3.435","article-title":"Theories of blood coagulation","volume":"15","author":"Howell","year":"1935","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2025.114218_b0015","first-page":"325","article-title":"Hemophilia","volume":"30","author":"Brinkhous","year":"1954","journal-title":"Bull. N. Y. Acad. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/ijlh.12214","article-title":"Thrombocytopenia: an update","volume":"36","author":"Smock","year":"2014","journal-title":"Int. J. Lab. Hematol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114218_b0025","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/08880019709030907","article-title":"von Willebrand factor: biological function and molecular defects","volume":"14","author":"Perutelli","year":"1997","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0030","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1538-7836.2005.01415.x","article-title":"Venous thromboembolism: disease burden, outcomes and risk factors","volume":"3","author":"Heit","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.intimp.2025.114218_b0035","first-page":"478","article-title":"The role of recombinant activated factor VII in the haematological management of elective orthopaedic surgery in haemophilia A patients with inhibitors","volume":"15","author":"Castaman","year":"2017","journal-title":"Blood Transfus."},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.0958-7578.2005.00564.x","article-title":"Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment","volume":"15","author":"Barnes","year":"2005","journal-title":"Transfus. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1076029607310920","article-title":"Use of recombinant factor VIIa in inherited and acquired von Willebrand disease","volume":"15","author":"Sucker","year":"2009","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"5","key":"10.1016\/j.intimp.2025.114218_b0050","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1182\/blood.V53.5.828.828","article-title":"Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion","volume":"53","author":"Seligsohn","year":"1979","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.intimp.2025.114218_b0055","first-page":"521","article-title":"Tissue factor: (patho)physiology and cellular biology","volume":"15","author":"Eilertsen","year":"2004","journal-title":"Blood Coagul. Fibrinol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114218_b0060","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/10409238.2015.1050550","article-title":"How it all starts: Initiation of the clotting cascade","volume":"50","author":"Smith","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.intimp.2025.114218_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.866751","article-title":"Thrombosis and inflammation-A dynamic interplay and the role of glycosaminoglycans and activated protein C","volume":"9","author":"Kohli","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-008-9099-z","article-title":"Vascular permeability, vascular hyperpermeability and angiogenesis","volume":"11","author":"Nagy","year":"2008","journal-title":"Angiogenesis"},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0075","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.395","article-title":"Coagulation factor VII and malignant progression of hepatocellular carcinoma","volume":"7","author":"Chen","year":"2016","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0080","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1182\/blood.V81.3.734.734","article-title":"Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation","volume":"81","author":"Morrissey","year":"1993","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0085","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0049-3848(90)90148-6","article-title":"Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody","volume":"59","author":"Fleck","year":"1990","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.114218_b0090","first-page":"1087","article-title":"Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis","volume":"134","author":"Drake","year":"1989","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0095","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-5223(97)70373-8","article-title":"Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study","volume":"113","author":"Ernofsson","year":"1997","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2025.114218_b0100","first-page":"S9","article-title":"Tissue factor expression by monocytes: regulation and pathophysiological roles","volume":"9","author":"Osterud","year":"1998","journal-title":"Blood Coagul. Fibrinol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114218_b0105","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1182\/bloodadvances.2019001379","article-title":"Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia","volume":"4","author":"Gangaraju","year":"2020","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0110","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1002\/ajh.26402","article-title":"Tissue factor activity is increased in neutrophils from -mutated essential thrombocythemia and polycythemia vera patients","volume":"97","author":"Reeves","year":"2022","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/01.ATV.0000151624.45775.13","article-title":"Tissue factor-factor VIIa signaling","volume":"25","author":"Rao","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2025.114218_b0120","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood.V87.9.3738.bloodjournal8793738","article-title":"Studies of the activation of factor VII bound to tissue factor","volume":"87","author":"Rao","year":"1996","journal-title":"Blood"},{"issue":"27","key":"10.1016\/j.intimp.2025.114218_b0125","doi-asserted-by":"crossref","first-page":"19089","DOI":"10.1016\/S0021-9258(18)41745-0","article-title":"Tissue factor-dependent autoactivation of human blood coagulation factor VII","volume":"267","author":"Yamamoto","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.intimp.2025.114218_b0130","doi-asserted-by":"crossref","first-page":"21489","DOI":"10.1016\/S0021-9258(20)80565-1","article-title":"Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism","volume":"268","author":"Neuenschwander","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0135","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1160\/TH09-11-0771","article-title":"Tissue factor and thrombosis: the clot starts here","volume":"104","author":"Owens","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.intimp.2025.114218_b0140","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1213\/ane.0b013e31819bceb1","article-title":"The role of tissue factor and factor VIIa in hemostasis","volume":"108","author":"Mackman","year":"2009","journal-title":"Anesth. Analg."},{"issue":"27","key":"10.1016\/j.intimp.2025.114218_b0145","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1021\/bi9525031","article-title":"Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa","volume":"35","author":"Scandura","year":"1996","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.intimp.2025.114218_b0150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4103\/0019-5049.144643","article-title":"Overview of the coagulation system","volume":"58","author":"Palta","year":"2014","journal-title":"Indian J. Anaesth."},{"issue":"26","key":"10.1016\/j.intimp.2025.114218_b0155","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1182\/blood-2010-10-315309","article-title":"Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction","volume":"117","author":"Corral-Rodriguez","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.intimp.2025.114218_b0160","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1182\/blood-2004-10-3939","article-title":"Thrombin-catalyzed activation of factor VIII with His substituted for Arg372 at the P1 site","volume":"105","author":"Nogami","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0165","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1742-4658.2005.05070.x","article-title":"Factor VIIIa regulates substrate delivery to the intrinsic factor X-activating complex","volume":"273","author":"Panteleev","year":"2006","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.intimp.2025.114218_b0170","first-page":"1424","article-title":"Does heart failure confer a hypercoagulable state? Virchow's triad revisited","volume":"33","author":"Lip","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114218_b0175","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-2007-985755","article-title":"Arterial thrombosis and the role of thrombophilia","volume":"33","author":"Boekholdt","year":"2007","journal-title":"Semin. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0180","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1357-2725(03)00244-9","article-title":"Antithrombin: in control of coagulation","volume":"36","author":"Quinsey","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.intimp.2025.114218_b0185","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231205279","article-title":"Antithrombin therapy: current state and future outlook","volume":"29","author":"Rodgers","year":"2023","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"21","key":"10.1016\/j.intimp.2025.114218_b0190","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V120.21.1109.1109","article-title":"Molecular basis of phospholipid synergy in promoting blood coagulation reactions","volume":"120","author":"Davis-Harrison","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.intimp.2025.114218_b0195","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.CIR.94.6.1226","article-title":"Identification of active tissue factor in human coronary atheroma","volume":"94","author":"Marmur","year":"1996","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0021-9150(99)00063-5","article-title":"Tissue factor in atherosclerosis","volume":"144","author":"Tremoli","year":"1999","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0205","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1073\/pnas.86.8.2839","article-title":"Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque","volume":"86","author":"Wilcox","year":"1989","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0210","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0002-9149(97)00801-1","article-title":"Comparison of plasma tissue factor levels in unstable and stable angina pectoris","volume":"81","author":"Misumi","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114218_b0215","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.ATV.0000130465.23430.74","article-title":"Role of tissue factor in hemostasis, thrombosis, and vascular development","volume":"24","author":"Mackman","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0220","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/hq0302.105375","article-title":"A human antibody that inhibits factor IX\/IXa function potently inhibits arterial thrombosis without increasing bleeding","volume":"22","author":"Refino","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114218_b0225","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jcp.27.7.517","article-title":"The structure and growth of valve-pocket thrombi in femoral veins","volume":"27","author":"Sevitt","year":"1974","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114218_b0230","first-page":"728","article-title":"Tissue factor activity of blood mononuclear cells is increased after total knee arthroplasty","volume":"102","author":"Johnson","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1160\/TH06-03-0141","article-title":"Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer","volume":"97","author":"Hron","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0240","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1538-7836.2005.01373.x","article-title":"The P-selectin, tissue factor, coagulation triad","volume":"3","author":"Polgar","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.intimp.2025.114218_b0245","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1182\/blood.V95.12.3678.012k45_3678_3682","article-title":"High levels of factor IX increase the risk of venous thrombosis","volume":"95","author":"AvH","year":"2000","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.intimp.2025.114218_b0250","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1074\/jbc.270.9.4650","article-title":"Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor","volume":"270","author":"Rottingen","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"46","key":"10.1016\/j.intimp.2025.114218_b0255","doi-asserted-by":"crossref","first-page":"29034","DOI":"10.1074\/jbc.271.46.29034","article-title":"Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active","volume":"271","author":"Camerer","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2025.114218_b0260","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1073\/pnas.97.10.5255","article-title":"Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa","volume":"97","author":"Camerer","year":"2000","journal-title":"PNAS"},{"issue":"14","key":"10.1016\/j.intimp.2025.114218_b0265","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1073\/pnas.141126698","article-title":"Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor","volume":"98","author":"Riewald","year":"2001","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.intimp.2025.114218_b0270","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","article-title":"Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation","volume":"64","author":"Vu","year":"1991","journal-title":"Cell"},{"issue":"6472","key":"10.1016\/j.intimp.2025.114218_b0275","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/368648a0","article-title":"Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface","volume":"368","author":"Gerszten","year":"1994","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0280","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0031-6997(24)01493-5","article-title":"Proteinase-activated receptors","volume":"53","author":"Macfarlane","year":"2001","journal-title":"Pharmacol. Rev."},{"issue":"47","key":"10.1016\/j.intimp.2025.114218_b0285","doi-asserted-by":"crossref","first-page":"32379","DOI":"10.1074\/jbc.M114.599332","article-title":"The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor\/coagulation factor VIIa","volume":"289","author":"Eriksson","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.114218_b0290","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12885-016-2375-1","article-title":"Cross-talk between the Tissue Factor\/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer","volume":"16","author":"Eriksson","year":"2016","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2025.114218_b0295","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1182\/blood-2010-09-310706","article-title":"Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protection","volume":"117","author":"Sen","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.intimp.2025.114218_b0300","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/jth.12272","article-title":"Analysis of tissue factor expression in various cell model systems: cryptic vs. active","volume":"11","author":"Kothari","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0305","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MOH.0000000000000232","article-title":"Integration of endothelial protease-activated receptor-1 inflammatory signaling by ubiquitin","volume":"23","author":"Grimsey","year":"2016","journal-title":"Curr. Opin. Hematol."},{"issue":"16","key":"10.1016\/j.intimp.2025.114218_b0310","doi-asserted-by":"crossref","first-page":"11849","DOI":"10.1074\/jbc.M609283200","article-title":"Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium","volume":"282","author":"Ghosh","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.intimp.2025.114218_b0315","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1073\/pnas.93.19.10212","article-title":"The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex","volume":"93","author":"Stearns-Kurosawa","year":"1996","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.intimp.2025.114218_b0320","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2014-05-578328","article-title":"Endothelial cell protein C receptor: a multiliganded and multifunctional receptor","volume":"124","author":"Mohan Rao","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.intimp.2025.114218_b0325","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1538-7836.2007.02648.x","article-title":"Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity","volume":"5","author":"L\u00f3pez-Sagaseta","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0330","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.2009.08060.x","article-title":"The endothelial cells downregulate the generation of factor VIIa through EPCR binding","volume":"149","author":"Puy","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114218_b0335","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood-2014-04-567297","article-title":"The endothelial protein C receptor enhances hemostasis of FVIIa administration in hemophilic mice in vivo","volume":"124","author":"Pavani","year":"2014","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2025.114218_b0340","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.thromres.2010.01.026","article-title":"Factor VIIa interaction with endothelial cells and endothelial cell protein C receptor","volume":"125","author":"Pendurthi","year":"2010","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.114218_b0345","first-page":"557","article-title":"Factor VIIa and its potential therapeutic use in bleeding-associated pathologies","volume":"100","author":"Hedner","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"21","key":"10.1016\/j.intimp.2025.114218_b0350","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1182\/blood-2017-10-813527","article-title":"Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1","volume":"131","author":"Kondreddy","year":"2018","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.intimp.2025.114218_b0355","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood.2020008417","article-title":"Factor VIIa induces extracellular vesicles from the endothelium: a potential mechanism for its hemostatic effect","volume":"137","author":"Das","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0360","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1182\/blood.2021012358","article-title":"Factor VIIa suppresses inflammation and barrier disruption through the release of EEVs and transfer of microRNA 10a","volume":"139","author":"Das","year":"2022","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.intimp.2025.114218_b0365","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1016\/j.jtha.2023.08.025","article-title":"Factor VIIa releases phosphatidylserine-enriched extracellular vesicles from endothelial cells by activating acid sphingomyelinase","volume":"21","author":"Das","year":"2023","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0370","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jtha.2023.10.021","article-title":"MicroRNA-10a enrichment in factor VIIa-released endothelial extracellular vesicles: potential mechanisms","volume":"22","author":"Das","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"24","key":"10.1016\/j.intimp.2025.114218_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415479","article-title":"The role of microRNAs in inflammation","volume":"23","author":"Das","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2025.114218_b0380","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1074\/jbc.M110.201228","article-title":"The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors","volume":"286","author":"Disse","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"38","key":"10.1016\/j.intimp.2025.114218_b0385","doi-asserted-by":"crossref","first-page":"13932","DOI":"10.1073\/pnas.0606411103","article-title":"Disulfide isomerization switches tissue factor from coagulation to cell signaling","volume":"103","author":"Ahamed","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2025.114218_b0390","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1182\/blood-2003-04-1149","article-title":"Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation","volume":"102","author":"Dorfleutner","year":"2003","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.intimp.2025.114218_b0395","doi-asserted-by":"crossref","first-page":"23038","DOI":"10.1074\/jbc.M401376200","article-title":"Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain","volume":"279","author":"Ahamed","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0400","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbamcr.2012.11.010","article-title":"p38\u03b1 phosphorylates serine 258 within the cytoplasmic domain of tissue factor and prevents its incorporation into cell-derived microparticles","volume":"1833","author":"Ettelaie","year":"2013","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.intimp.2025.114218_b0405","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1874383800903010058","article-title":"Spectroscopic characterization of successive phosphorylation of the tissue factor cytoplasmic region","volume":"3","author":"Sen","year":"2009","journal-title":"Open Spectrosc. J."},{"issue":"6","key":"10.1016\/j.intimp.2025.114218_b0410","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3324\/haematol.2017.183087","article-title":"Structural and cellular mechanisms of peptidyl-prolyl isomerase Pin1-mediated enhancement of Tissue Factor gene expression, protein half-life, and pro-coagulant activity","volume":"103","author":"Kurakula","year":"2018","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.intimp.2025.114218_b0415","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/jth.13717","article-title":"Prothrombotic aspects of sickle cell disease","volume":"15","author":"Sparkenbaugh","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.intimp.2025.114218_b0420","doi-asserted-by":"crossref","first-page":"L911","DOI":"10.1152\/ajplung.00372.2003","article-title":"p38 MAP kinase-dependent regulation of endothelial cell permeability","volume":"287","author":"Borbiev","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0425","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/hh1301.092661","article-title":"Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists","volume":"89","author":"Hamilton","year":"2001","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.intimp.2025.114218_b0430","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.jtha.2024.07.022","article-title":"Coagulation protease-induced extracellular vesicles: their potential effects on coagulation and inflammation","volume":"22","author":"Das","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2025.114218_b0435","article-title":"Blood cells and endothelial barrier function","volume":"3","author":"Rodrigues","year":"2015","journal-title":"Tissue Barriers"},{"issue":"17","key":"10.1016\/j.intimp.2025.114218_b0440","doi-asserted-by":"crossref","first-page":"17286","DOI":"10.1074\/jbc.M412427200","article-title":"Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation","volume":"280","author":"Finigan","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0445","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1160\/TH08-02-0127","article-title":"Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand","volume":"100","author":"Bae","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"15","key":"10.1016\/j.intimp.2025.114218_b0450","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1073\/pnas.0810687106","article-title":"Caveolae are required for protease-selective signaling by protease-activated receptor-1","volume":"106","author":"Russo","year":"2009","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0455","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1038\/emm.2013.73","article-title":"Signaling mechanisms of glucose-induced F-actin remodeling in pancreatic islet \u03b2 cells","volume":"45","author":"Kalwat","year":"2013","journal-title":"Exp. Mol. Med."},{"issue":"32","key":"10.1016\/j.intimp.2025.114218_b0460","doi-asserted-by":"crossref","first-page":"30188","DOI":"10.1074\/jbc.M102061200","article-title":"Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-\u03b1 secretion through IKK regulation of NF-\u03baB*","volume":"276","author":"Sanlioglu","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2025.114218_b0465","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1182\/blood.V98.5.1429","article-title":"Lipopolysaccharide activation of the MEK-ERK1\/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression","volume":"98","author":"Guha","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0470","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jcb.23330","article-title":"LPS induces phosphorylation of actin-regulatory proteins leading to actin reassembly and macrophage motility","volume":"113","author":"Kleveta","year":"2012","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0475","article-title":"Different concentrations of lipopolysaccharide regulate barrier function through the PI3K\/Akt signalling pathway in human pulmonary microvascular endothelial cells","volume":"8","author":"Zheng","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2025.114218_b0480","doi-asserted-by":"crossref","first-page":"E982","DOI":"10.1073\/pnas.1718600115","article-title":"PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury","volume":"115","author":"De Ceunynck","year":"2018","journal-title":"PNAS"},{"issue":"49","key":"10.1016\/j.intimp.2025.114218_b0485","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106623118","article-title":"aPC\/PAR1 confers endothelial anti-apoptotic activity via a discrete, \u03b2-arrestin-2-mediated SphK1-S1PR1-Akt signaling axis","volume":"118","author":"Molinar-Inglis","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2025.114218_b0490","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1211597","article-title":"Endothelial APC\/PAR1 distinctly regulates cytokine-induced pro-inflammatory VCAM-1 expression","volume":"10","author":"Birch","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0495","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1073\/pnas.0611493104","article-title":"Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells","volume":"104","author":"Bae","year":"2007","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.intimp.2025.114218_b0500","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood-2007-06-096651","article-title":"The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells","volume":"110","author":"Bae","year":"2007","journal-title":"Blood"},{"issue":"50","key":"10.1016\/j.intimp.2025.114218_b0505","doi-asserted-by":"crossref","first-page":"E1372","DOI":"10.1073\/pnas.1112482108","article-title":"Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through \u03b2-arrestin and dishevelled-2 scaffolds","volume":"108","author":"Soh","year":"2011","journal-title":"PNAS"},{"issue":"23","key":"10.1016\/j.intimp.2025.114218_b0510","doi-asserted-by":"crossref","first-page":"8603","DOI":"10.1073\/pnas.0402851101","article-title":"beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha","volume":"101","author":"Witherow","year":"2004","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.intimp.2025.114218_b0515","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1073\/pnas.0700305104","article-title":"Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase\/Akt signaling pathway","volume":"104","author":"Zhang","year":"2007","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.intimp.2025.114218_b0520","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(95)90070-5","article-title":"The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation","volume":"81","author":"Hsu","year":"1995","journal-title":"Cell."},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0525","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)80984-8","article-title":"TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways","volume":"84","author":"Hsu","year":"1996","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0530","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.114218_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2019.100030","article-title":"Dopamine activates NF-\u03baB and primes the NLRP3 inflammasome in primary human macrophages","volume":"2","author":"Nolan","year":"2020","journal-title":"Brain Behavior Immunity - Health"},{"issue":"4","key":"10.1016\/j.intimp.2025.114218_b0540","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.immuni.2004.10.001","article-title":"Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction","volume":"21","author":"Muppidi","year":"2004","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.intimp.2025.114218_b0545","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1074-7613(03)00092-X","article-title":"Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation","volume":"18","author":"Legler","year":"2003","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0550","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1111\/jth.15768","article-title":"Factor VIIa treatment increases circulating extracellular vesicles in hemophilia patients: implications for the therapeutic hemostatic effect of FVIIa","volume":"20","author":"Das","year":"2022","journal-title":"J. Thromb. Haemost."},{"issue":"26","key":"10.1016\/j.intimp.2025.114218_b0555","doi-asserted-by":"crossref","first-page":"25048","DOI":"10.1074\/jbc.M414090200","article-title":"Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1","volume":"280","author":"McLaughlin","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0560","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1182\/blood-2005-01-0334","article-title":"APC signaling: tickling PAR1 for barrier protection?","volume":"105","author":"Camerer","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0565","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1152\/physrev.00028.2003","article-title":"Protease-activated receptors: contribution to physiology and disease","volume":"84","author":"Ossovskaya","year":"2004","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0570","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2006-09-003004","article-title":"The cytoprotective protein C pathway","volume":"109","author":"Mosnier","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.intimp.2025.114218_b0575","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood.V92.4.1259","article-title":"Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106)","volume":"92","author":"Kaplanski","year":"1998","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.intimp.2025.114218_b0580","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1074\/jbc.C100017200","article-title":"Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis","volume":"276","author":"Joyce","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0585","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1160\/TH08-09-0568","article-title":"Thrombin inhibits nuclear factor kappaB and RhoA pathways in cytokine-stimulated vascular endothelial cells when EPCR is occupied by protein C","volume":"101","author":"Bae","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.intimp.2025.114218_b0590","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood-2006-04-014175","article-title":"Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2","volume":"108","author":"Sapet","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0595","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/CIRCRESAHA.108.183285","article-title":"TRAIL\/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro","volume":"104","author":"Simoncini","year":"2009","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0600","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/CIRCRESAHA.109.196840","article-title":"On the trail of microparticles","volume":"104","author":"Mackman","year":"2009","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0605","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/cc1333","article-title":"The normal role of Activated Protein C in maintaining homeostasis and its relevance to critical illness","volume":"5","author":"Esmon","year":"2001","journal-title":"Crit. Care."},{"issue":"26","key":"10.1016\/j.intimp.2025.114218_b0610","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1182\/blood-2012-08-452169","article-title":"Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46","volume":"120","author":"Mosnier","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0615","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1538-7836.2012.04825.x","article-title":"Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects","volume":"10","author":"Schuepbach","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"42","key":"10.1016\/j.intimp.2025.114218_b0620","doi-asserted-by":"crossref","first-page":"26486","DOI":"10.1016\/S0021-9258(18)47220-1","article-title":"Identification, cloning, and regulation of a novel endothelial cell protein C\/activated protein C receptor","volume":"269","author":"Fukudome","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"5574","key":"10.1016\/j.intimp.2025.114218_b0625","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1071699","article-title":"Activation of endothelial cell protease activated receptor 1 by the protein C pathway","volume":"296","author":"Riewald","year":"2002","journal-title":"Science"},{"issue":"42","key":"10.1016\/j.intimp.2025.114218_b0630","doi-asserted-by":"crossref","first-page":"26279","DOI":"10.1074\/jbc.272.42.26279","article-title":"The interaction between the endothelial cell protein C receptor and protein C is dictated by the gamma-carboxyglutamic acid domain of protein C","volume":"272","author":"Regan","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"50","key":"10.1016\/j.intimp.2025.114218_b0635","doi-asserted-by":"crossref","first-page":"E1372","DOI":"10.1073\/pnas.1112482108","article-title":"Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through beta-arrestin and dishevelled-2 scaffolds","volume":"108","author":"Soh","year":"2011","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.intimp.2025.114218_b0640","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2004-05-1896","article-title":"Activated protein C induces the release of microparticle-associated endothelial protein C receptor","volume":"105","author":"Perez-Casal","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0645","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3324\/haematol.13547","article-title":"Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects","volume":"94","author":"Perez-Casal","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.intimp.2025.114218_b0650","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2023023518","article-title":"Activated protein C-released endothelial extracellular vesicles: a potential mechanism for their cytoprotective effects","author":"Das","year":"2024","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.intimp.2025.114218_b0655","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1111\/j.1538-7836.2005.01610.x","article-title":"Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling","volume":"3","author":"Feistritzer","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2025.114218_b0660","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2013.09.006","article-title":"Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue","volume":"718","author":"Bukowska","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0665","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbamcr.2006.04.010","article-title":"Factor Xa and thrombin evoke additive calcium and proinflammatory responses in endothelial cells subjected to coagulation","volume":"1763","author":"Daubie","year":"2006","journal-title":"Biochim. Biophys. Acta."},{"issue":"8","key":"10.1016\/j.intimp.2025.114218_b0670","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.4049\/jimmunol.161.8.4318","article-title":"Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells","volume":"161","author":"Senden","year":"1998","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114218_b0675","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/CIRCRESAHA.107.167759","article-title":"Factor Xa binding to annexin 2 mediates signal transduction via protease-activated receptor 1","volume":"102","author":"Bhattacharjee","year":"2008","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.114218_b0680","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1538-7836.2009.03682.x","article-title":"Coagulation factor Xa cleaves protease-activated receptor-1 and mediates signaling dependent on binding to the endothelial protein C receptor","volume":"8","author":"Schuepbach","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0685","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yexcr.2004.10.021","article-title":"Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation","volume":"304","author":"Blanc-Brude","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.intimp.2025.114218_b0690","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fendo.2014.00067","article-title":"Biased signaling of protease-activated receptors","volume":"5","author":"Zhao","year":"2014","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0695","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/cvr\/cvt112","article-title":"Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells","volume":"99","author":"Bohm","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.114218_b0700","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/hae.12140","article-title":"Real-world outcomes with recombinant factor VIIa treatment of acute bleeds in haemophilia patients with inhibitors: results from the international ONE registry","volume":"19","author":"Chambost","year":"2013","journal-title":"Haemophilia"},{"issue":"4 Suppl. 12","key":"10.1016\/j.intimp.2025.114218_b0705","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0037-1963(01)90142-8","article-title":"Effect of recombinant factor VIIa (Novoseven) on thrombocytopenia-like conditions in vitro","volume":"38","author":"Kjalke","year":"2001","journal-title":"Semin. Hematol."},{"issue":"13","key":"10.1016\/j.intimp.2025.114218_b0710","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2004-06-2223","article-title":"The use of recombinant factor VIIa in the treatment of bleeding disorders","volume":"104","author":"Roberts","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.intimp.2025.114218_b0715","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1111\/j.1538-7836.2006.02166.x","article-title":"Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors","volume":"4","author":"Hedner","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.intimp.2025.114218_b0720","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1182\/blood-2009-03-208900","article-title":"Endothelial cell protein C receptor cellular localization and trafficking: potential functional implications","volume":"114","author":"Nayak","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.intimp.2025.114218_b0725","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/j.1538-7836.2012.04917.x","article-title":"Endothelial cell protein C receptor\u2010mediated redistribution and tissue\u2010level accumulation of factor VIIa","volume":"10","author":"Clark","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.intimp.2025.114218_b0730","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/jth.13502","article-title":"LDL receptor-related protein 1 contributes to the clearance of the activated factor VII\u2013antithrombin complex","volume":"14","author":"Fazavana","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.intimp.2025.114218_b0735","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/ATVBAHA.115.305996","article-title":"Tissue factor pathway inhibitor","volume":"36","author":"Mast","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114218_b0740","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1172\/JCI32878","article-title":"Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality","volume":"118","author":"Aljamali","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"20","key":"10.1016\/j.intimp.2025.114218_b0745","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.114218_b0750","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3324\/haematol.2019.232132","article-title":"Hemophilia therapy: the future has begun","volume":"105","author":"Mannucci","year":"2020","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.intimp.2025.114218_b0755","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa2002699","article-title":"BIVV001 fusion protein as factor VIII replacement therapy for hemophilia A","volume":"383","author":"Konkle","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.intimp.2025.114218_b0760","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1182\/blood-2015-06-650226","article-title":"A first-in-human phase 1 study of ACE910, a novel factor VIII-mimetic bispecific antibody, in healthy subjects","volume":"127","author":"Uchida","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.intimp.2025.114218_b0765","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/17474086.2022.2131526","article-title":"Emicizumab: a novel drug in hemophilia A prophylaxis \u2013 a narrative review","volume":"15","author":"Mazurkiewicz","year":"2022","journal-title":"Expert Rev. Hematol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925002085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925002085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:16:51Z","timestamp":1763785011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925002085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":153,"alternative-id":["S1567576925002085"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114218","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond coagulation: Coagulation protease factor VIIa in cytoprotective response","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114218"}}